Poster | DIA 2024 | An Evaluation of PMRCs for Assessing Data in Racial and Ethnic Populations Underrepresented in Pivotal Trials Supporting Novel Oncology Approvals 2012-2023
White Paper | 2023 Annual Meeting | Incorporating Pragmatic Elements in Study Designs to Enhance Oncology Randomized Clinical Trials
White Paper | Incorporating Pragmatic Elements in Study Designs to Enhance Oncology Randomized Clinical Trials
White Paper | 2023 Annual Meeting | Interpreting Data from Dose-Finding Studies in Early Phase Oncology Trials to Determine the Optimal Dose
Poster | 2023 ASCO Annual Meeting | Impact of COVID-19 pandemic mitigation strategies on industry and NCI cancer treatment trials.
Background: The onset of the COVID-19 pandemic resulted in major disruptions in enrollment and conduct of cancer clinical trials. In response, regulators allowed modifications to traditional trial processes to enable clinical research and care to continue. The American Society of Clinical Oncology and Friends of Cancer Research established a task force to evaluate how sponsors…